Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.

标题
Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 41, Issue 16_suppl, Pages 10008-10008
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2023-06-05
DOI
10.1200/jco.2023.41.16_suppl.10008

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started